Ginkgo biloba extract (EGb 761) prevents the ischemic brain injury-induced decrease in parvalbumin expression.
- Author:
Jin Hee SUNG
1
;
Fawad Ali SHAH
;
Eun Hae CHO
;
Sang Ah GIM
;
Seong Jun JEON
;
Kyung Min KIM
;
Young Min KIM
;
Myeong Ok KIM
;
Phil Ok KOH
Author Information
- Publication Type:Original Article
- Keywords: EGb 761; neuroprotection; parvalbumin
- MeSH: Adult; Animals; Blotting, Western; Brain; Brain Injuries; Calcium; Cell Death; Cerebral Cortex; Ginkgo biloba; Humans; Infarction, Middle Cerebral Artery; Ischemia; Male; Neurons; Neuroprotective Agents; Plant Extracts; Rats, Sprague-Dawley
- From:Laboratory Animal Research 2012;28(2):77-82
- CountryRepublic of Korea
- Language:English
- Abstract: Ginkgo biloba extract (EGb 761) exerts a neuroprotective effect against ischemic brain injury through an anti-apoptotic mechanism. Parvalbumin is a calcium buffering protein that plays an important role in modulating intracellular calcium concentration and regulating apoptotic cell death. The aim of this study was to investigate whether EGb 761 affects parvalbumin expression in cerebral ischemic injury. Adult male Sprague-Dawley rats were treated with vehicle or EGb 761 (100 mg/kg) prior to middle cerebral artery occlusion (MCAO) and cerebral cortex tissues were collected 24 h after MCAO. A proteomic approach revealed a reduction in parvalbumin expression in the vehicle-treated animals, whereas EGb 761 pretreatment attenuates the ischemic injury-induced decrease in parvalbumin expression. RT-PCR and Western blot analyses clearly confirmed the fact that EGb 761 prevents the injury-induced decrease in parvalbumin. Moreover, the results of immunohistochemical staining showed that the number of parvalbumin-positive cells was lower in vehicle-treated animals than in sham-operated animals, and EGb 761 averted this decrease. Thus, these results suggest that the maintenance of parvalbumin expression is associated with the neuroprotective function of EGb 761 against neuronal damage induced by ischemia.
